Hepatitis C treatment for people awaiting trial in jail
Treatments studied
Part of Digestive system, Infections clinical trials.
This study offers a once-daily pill (Epclusa) to treat hepatitis C for people in jail who have never taken HCV medicine before. The goal is to see if starting treatment while incarcerated and continuing after release can cure the infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently in jail at RIDOC and are at least 18 years old.
- You are awaiting trial (not yet sentenced) and speak English.
- You have active hepatitis C (detected in a blood test within the last 3 months) and have never been treated for it before.
- You have injected drugs at least once and do not have cirrhosis.
- You are willing to take a medication called Epclusa (sofosbuvir/velpatasvir), continue it after release, and be contacted after jail.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a pill combination (sofosbuvir/velpatasvir) to cure hepatitis C. It aims to make treatment simple and accessible, and you can join even if you've had treatment before (if it failed or you got reinfected).
This study offers a one-stop approach to testing and treating hepatitis C during a single emergency room visit. If you test positive, you may receive treatment right away, potentially avoiding extra appointments and helping you get cured faster.
This study tests a team-based approach — a pharmacist, doctor, and patient navigator working together — to help people living in permanent supportive housing get hepatitis C care. If you have hepatitis C and live in DESC housing, the study will check how well this team helps you through treatment over 2 years.
This study compares two ways to treat hepatitis C: getting treatment at a local clinic near you, or the usual care at a central hospital. It aims to see if treatment at local clinics is safe, effective, and more convenient for patients.
This trial looks at hepatitis C treatment for people whose last antiviral medicines did not fully clear the virus. It may help by testing a study drug approach for people in Pakistan who still have active hepatitis C infection.
This study tests a better way to start long-acting HIV prevention (PrEP) and buprenorphine for opioid use disorder while people are in jail, to see if it helps them stay healthy after release. If you are soon leaving jail and have opioid use disorder, you may be able to join.
Hear when a new HEPATITIS C (HCV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.